Viking Therapeutics' shares plunged after mixed phase 2 results for a GLP-1 candidate. However, the data wasn't nearly as bad ...

The investigational GLP-1 receptor agonist MET-097i, which may be able to be dosed just once a month, yielded weight loss of ...

In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...

Pilot study met key 3-month efficacy endpoint with strong statistical significance (p=0.014); Revita-treated patients lost an ...

New data unveiled on Friday has Fractyl Health saying that Revita could be the first therapy to preserve weight loss after ...

A new large-scale study came to the conclusion that weight-loss surgery gives people with type 2 diabetes and obesity a ...

"However, in clinical trials, GLP-1 agonists reduce mortality by about 20%, and no single pharmaceutical treatment has ever ...

Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists.

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

GLP-1 RA Effects Beyond Glycaemic Control A RECENT network meta-analysis suggests that GLP-1 receptor agonists (GLP-1 RAs) ...